Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 17,833 |
|
|||||
| News | - | ||||||
| Day High | 0.9586 | Low High |
|||||
| Day Low | 0.92201 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Notable Labs Ltd | NTBL | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.95 | 16:32:17 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.94 | 0.92201 | 0.9586 | 0.95 | 0.95 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 139 | 17,833 | US$ 0.9318956 | US$ 16,618 | - | 0.833 - 5.27 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:09:23 | 1 | US$ 0.9582 | USD |
Notable Labs Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.57M | 9.02M | - | 310k | -11.26M | -1.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Notable Labs News
| Date | Time | Source | News Article |
|---|---|---|---|
| 12/13/2023 | 11:00 | PR Newswire (US) | Notable Labs Donates $60,000 to MDS Foundation to Accelerate.. |
| 12/11/2023 | 11:00 | PR Newswire (US) | Notable Labs Funds Myelodysplastic Syndromes Foundation with.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NTBL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.97 | 1.07 | 0.861 | 0.9446818 | 75,375 | -0.02 | -2.06% |
| 1 Month | 1.66 | 1.6991 | 0.833 | 1.07 | 69,746 | -0.71 | -42.77% |
| 3 Months | 1.20 | 1.94 | 0.833 | 1.37 | 85,996 | -0.25 | -20.83% |
| 6 Months | 2.69 | 4.24 | 0.833 | 1.44 | 120,768 | -1.74 | -64.68% |
| 1 Year | 4.50 | 5.27 | 0.833 | 1.63 | 118,795 | -3.55 | -78.89% |
| 3 Years | 4.50 | 5.27 | 0.833 | 1.63 | 118,795 | -3.55 | -78.89% |
| 5 Years | 4.50 | 5.27 | 0.833 | 1.63 | 118,795 | -3.55 | -78.89% |
Notable Labs Description
| Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics. |
